Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Buy
53
MHLD Quote, Financials, Valuation and Earnings
Last price:
$1.39
Seasonality move
:
7.26%
Day range:
$1.21 - $1.33
52-week range:
$0.55 - $2.27
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.41x
P/B ratio:
2.72x
Volume:
154.8K
Avg. volume:
197.1K
1-year change:
-41.51%
Market cap:
$122.8M
Revenue:
$87.7M
EPS (TTM):
-$2.03
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Maiden Holdings has 61.29% upside to fair value with a price target of -- per share.
MHLD vs. S&P 500
-
Over the past 5 trading days, Maiden Holdings has overperformed the S&P 500 by 10.18% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Maiden Holdings does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Maiden Holdings has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Maiden Holdings reported revenues of $27.7M.
Earnings Growth
-
Maiden Holdings has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Maiden Holdings reported earnings per share of -$1.59.
Enterprise value:
126.2M
EV / Invested capital:
--
Price / LTM sales:
1.41x
EV / EBIT:
--
EV / Revenue:
1.44x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-1.87x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
-14.16%
Net Income Margin (TTM):
-229.17%
Return On Equity:
-101.51%
Return On Invested Capital:
-44.4%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $66.4M | $83.5M | $87.7M | $20.3M | $27.7M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $0.63 | -$0.37 | -$2.03 | -$0.20 | -$1.59 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.5B | $1.8B | $1.4B | $1B | $843.5M | |
| Total Assets | $2.9B | $2.3B | $1.8B | $1.5B | $1.3B | |
| Current Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.4B | $1.9B | $1.6B | $1.3B | $1.3B | |
| Total Equity | $527.8M | $384.3M | $284.6M | $249.2M | $45.2M | |
| Total Debt | $255.1M | $255.3M | $255.6M | $254.6M | $254.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$195.9M | -$59.8M | -$67.4M | $6.2M | -$48.3M | |
| Cash From Investing | $188.8M | $58.5M | $77.7M | $7.4M | -$29.3M | |
| Cash From Financing | -$11M | -$3M | -$3.7M | -$1M | -$602K | |
| Free Cash Flow | -$195.9M | -$59.8M | -$67.4M | $6.2M | -$48.3M | |
MHLD
Sector
Market Cap
$122.8M
$603.7M
Price % of 52-Week High
54.63%
84.45%
Dividend Yield
0%
2.05%
Shareholder Yield
2.21%
3.98%
1-Year Price Total Return
-41.51%
9.07%
Beta (5-Year)
1.596
0.555
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$1.12
200-day SMA
Sell
Level
$1.41
Bollinger Bands (100)
Buy
Level
0.78 - 1.32
Chaikin Money Flow
Sell
Level
-43.6M
20-day SMA
Buy
Level
$0.96
Relative Strength Index (RSI14)
Buy
Level
66.99
ADX Line
Buy
Level
35.7
Williams %R
Neutral
Level
-22.0713
50-day SMA
Buy
Level
$0.86
MACD (12, 26)
Buy
Level
0.11
25-day Aroon Oscillator
Buy
Level
60
On Balance Volume
Neutral
Level
42.6M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
Sell
CA Score
(Annual)
Level (-2.8405)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (3)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Maiden Holdings Ltd provides reinsurance products and services to regional and specialty property and casualty insurers. The company operates in two segments: AmTrust Reinsurance and Diversified Reinsurance. The AmTrust Reinsurance segment provides products that cover workers' compensation, commercial package, commercial auto, and extended warranty. The Diversified Reinsurance segment provides small and midsize regional and specialty insurers with reinsurance capital products. Its revenues also include fee income earned from both its GLS business and IIS business as well as income generated from its investment portfolio.
Stock Forecast FAQ
In the current month, MHLD has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MHLD average analyst price target in the past 3 months is --.
-
Where Will Maiden Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that Maiden Holdings share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Maiden Holdings?
Analysts are divided on their view about Maiden Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Maiden Holdings is a Sell and believe this share price will drop from its current level to --.
-
What Is Maiden Holdings's Price Target?
The price target for Maiden Holdings over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is MHLD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Maiden Holdings is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of MHLD?
You can purchase shares of Maiden Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Maiden Holdings shares.
-
What Is The Maiden Holdings Share Price Today?
Maiden Holdings was last trading at $1.39 per share. This represents the most recent stock quote for Maiden Holdings. Yesterday, Maiden Holdings closed at $1.24 per share.
-
How To Buy Maiden Holdings Stock Online?
In order to purchase Maiden Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
55
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
85
HIMS alert for Apr 30
Hims & Hers Health [HIMS] is down 5.48% over the past day.
Buy
54
EAT alert for Apr 30
Brinker International [EAT] is down 1.82% over the past day.
Sell
16
NSP alert for Apr 30
Insperity [NSP] is down 3.3% over the past day.
